Go to the list of all blogs
Joma Foster's Avatar
published in Blogs
Jul 17, 2026
Robinhood (HOOD) Flat Over 30 Days but +17% This Quarter: Catalysts, Valuation, and What Comes Next

Robinhood (HOOD) Flat Over 30 Days but +17% This Quarter: Catalysts, Valuation, and What Comes Next

Key Takeaways

  • HOOD shares have remained effectively flat over the last 30 days, closing at $106.02 on July 16, 2026, versus $105.20 on June 17 — a modest gain of approximately 0.8%.
  • Over the broader quarter, the stock has rallied roughly 17%, recovering sharply from its post-Q1-earnings trough near $71 in late April.
  • Key catalysts include the July 4 launch of Trump Accounts — built on Robinhood's technology — the unveiling of Robinhood Chain, a Layer 2 blockchain, and plans for AI-powered trading agents.
  • Wall Street remains broadly constructive: Goldman Sachs raised its price target to $137, Compass Point to $130, and Mizuho to $130, all maintaining Buy-equivalent ratings.
  • Q2 2026 earnings, due July 29, represent the next major inflection point, with consensus expectations of $0.41 EPS on $1.24 billion in revenue.
  • Insider selling by CEO Vlad Tenev and several directors under pre-arranged 10b5-1 plans has introduced a note of caution alongside high valuation multiples.

Where HOOD Stands in the Current Market

Robinhood Markets (HOOD) has experienced a volatile yet ultimately flat month, with the stock oscillating between roughly $93 and $120. After a sharp 50% drawdown following two consecutive quarterly earnings misses, shares have rebounded approximately 40% from their late-April low. Institutional ownership remains exceptionally high at over 93%, signaling deep conviction among professional investors even as retail sentiment fluctuates. The stock currently trades at approximately 51 times trailing earnings, above its 200-day moving average of roughly $89, though momentum indicators have turned mixed following the most recent pullback from intra-quarter highs. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Robinhood Markets (HOOD) Business Overview and Competitive Position

Robinhood Markets is a U.S.-based financial services platform best known for pioneering commission-free trading through a mobile-first interface. Founded in 2013 and headquartered in Menlo Park, California, the company has expanded far beyond its original stock-trading roots to encompass options, cryptocurrency, futures, prediction markets, and a growing suite of banking products — including cash management, credit cards, and the Robinhood Gold premium membership. With approximately 27.4 million funded accounts and 4.3 million Gold subscribers, Robinhood has cemented itself as the dominant retail brokerage for younger investors. Mizuho analysts recently described the company as having the potential to become the first true global "hyperscaler" of online brokerages, citing its best-in-class user experience and Gen Z appeal. International expansion — notably into Europe and Asia — alongside blockchain infrastructure and AI-driven trading tools, represents the next frontier of the company's growth strategy.

Recent Developments Driving HOOD

The past 30 days have been among the most eventful in Robinhood's recent history. On July 4, the White House announced the official launch of the Trump Accounts app — a national initiative for which Robinhood serves as technology developer and initial trustee, alongside BK. The program positions Robinhood at the center of a long-term, government-backed financial savings program with a potential user base in the tens of millions.

Simultaneously, Robinhood hosted a product showcase event unveiling Robinhood Chain, a Layer 2 blockchain built on the Arbitrum framework and integrated with decentralized finance protocols such as Chainlink and Uniswap. The company also introduced tokenized stocks available in over 120 jurisdictions and announced plans for AI-powered trading agents capable of autonomous trade execution across equities, derivatives, and crypto. These announcements catalyzed a 14% weekly surge in HOOD shares in early July.

On the analyst front, the stock received a cascade of price-target increases: Goldman Sachs raised its target to $137 (Buy), Compass Point to $130 (Buy) citing expectations of an 18% Q2 EBITDA beat, Mizuho to $130 (Outperform), and Barclays to $122 (Overweight). Meanwhile, Bloomberg reported Robinhood is seeking to sell at least $400 million in asset-backed securities tied to credit card receivables, underscoring its push beyond brokerage into consumer lending. On the cost side, the company announced a 10% workforce reduction on June 16, which Compass Point noted should support margin expansion in the second half of 2026.

Tempering the optimism, CEO Vlad Tenev sold 375,000 shares — roughly 50% of his reported stake — at an average price of $116.17 on July 6 under a Rule 10b5-1 plan, and director Paula Loop also trimmed her position. These transactions, while pre-scheduled, have drawn investor attention given the stock's elevated valuation.

2026 Outlook and What Investors Should Watch

The most immediate catalyst for HOOD is the Q2 2026 earnings report on July 29. Wall Street expects $0.41 in earnings per share on $1.24 billion in revenue, representing roughly 25% year-over-year top-line growth. A beat could validate the recent analyst upgrades and propel the stock toward the upper end of its $82–$155 analyst target range. However, cryptocurrency trading revenue remains a wild card: after surging 98% year-over-year in Q2 2025, crypto revenue declined 47% in Q1 2026 amid Bitcoin's pullback, and another weak quarter could weigh on results.

Beyond earnings, investors should monitor the rollout of the Trump Accounts program, European expansion fueled by the WonderFi acquisition, adoption of the Robinhood Chain blockchain, and progress on AI agent trading capabilities. The company's credit card asset-backed securities offering, if successful, could open a new funding channel and validate its consumer finance ambitions. Key risks include continued crypto market weakness, execution risk around multiple simultaneous product launches, elevated valuation multiples, and the potential for further insider selling. The prediction markets segment — where Q2 volumes were 57% above Q4 2025 levels — should benefit from the upcoming football season in the second half, offering another potential growth lever independent of crypto cycles.

Exploring Automated Strategies for Stocks Like HOOD

When I look for data-driven ways to approach names like HOOD, I often review Tickeron's Trending AI Robots page. It offers a curated view of active AI trading bots that operate across thousands of tickers using various strategies, timeframes, and performance profiles. The Trending section highlights only the most relevant and top-performing bots at any given moment, which can help identify approaches aligned with current market conditions. Bots vary from short-term momentum plays to longer-duration trend-following models, giving flexibility to match different risk tolerances and horizons. Exploring this page can provide a practical starting point for those considering algorithmic elements in their process.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HOOD

HOOD's Indicator enters downward trend

The Aroon Indicator for HOOD entered a downward trend on August 06, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 212 similar instances where the Aroon Indicator formed such a pattern. In of the 212 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on July 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HOOD as a result. In of 70 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HOOD turned negative on July 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

HOOD moved below its 50-day moving average on July 24, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HOOD crossed bearishly below the 50-day moving average on July 31, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HOOD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HOOD broke above its upper Bollinger Band on July 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HOOD's RSI Oscillator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 59 cases where HOOD's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HOOD advanced for three days, in of 316 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HOOD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.606) is normal, around the industry mean (4.148). P/E Ratio (40.137) is within average values for comparable stocks, (20.994). Projected Growth (PEG Ratio) (2.059) is also within normal values, averaging (1.663). Dividend Yield (0.000) settles around the average of (0.033) among similar stocks. P/S Ratio (16.920) is also within normal values, averaging (31.056).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HOOD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 13.14B. The market cap for tickers in the group ranges from 13 to 928.5B. PKRSF holds the highest valuation in this group at 928.5B. The lowest valued company is BFCH at 13.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was 1%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was -13%. USDE experienced the highest price growth at 36%, while TOP experienced the biggest fall at -80%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -38%. For the same stocks of the Industry, the average monthly volume growth was -25% and the average quarterly volume growth was -69%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 63
P/E Growth Rating: 70
Price Growth Rating: 63
SMR Rating: 76
Profit Risk Rating: 86
Seasonality Score: -7 (-100 ... +100)
View a ticker or compare two or three
HOOD
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry InvestmentBanksBrokers

Profile
Details
Industry
N/A
Address
85 Willow Road
Phone
+1 844 428-5411
Employees
2900
Web
https://www.robinhood.com
Interact to see
Advertisement
Novartis (NVS) reports Q4/FY 2025 earnings on February 4, 2026, with consensus calling for ~$1.99 EPS on ~$13.7 billion in revenue. Sanofi (SNY) delivered strong FY 2025 results on January 29, reporting €43.6 billion in sales (+9.9% CER) and 15% business EPS growth.
Novo Nordisk (NVO) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $11.96 billion in revenue and $0.89 EPS, reflecting a moderation in GLP-1 growth. Eli Lilly (LLY) is expected to report around the same time, with projections of $17.87 billion in revenue and $6.99 EPS, driven by continued volume gains from Mounjaro and Zepbound.
MUFG is expected to report Q3 FY2026 EPS of about $0.30, broadly in line with its recent pattern of earnings beats.
Banco Santander (SAN) reports Q4 2025 earnings on February 4, 2026, following record nine-month attributable profit of €10.3 billion, up 11% year over year.
Uber (UBER) reports Q4 2025 earnings on February 4, 2026, with consensus estimates of $0.78 EPS and $14.32 billion in revenue, up about 20% year over year.
Qualcomm’s Q1 FY2026 report, covering the period ended December 28, 2025, arrives amid a pivotal shift in the semiconductor landscape. While handset growth moderates, the company is expanding in automotive, IoT, and AI-enabled devices.
UBS Group AG reports Q4 2025 earnings on February 4, 2026, with consensus EPS ranging $0.25–$0.67 and revenue around $11.62 billion, down YoY. HSBC Holdings plc reports Q4 earnings on February 25, 2026, with consensus EPS ~$1.57; Q3 showed resilient net interest income despite $1.4B in legal provisions.
Boston Scientific’s Q4 caps a transformative year, driven by ~15.5% organic growth from WATCHMAN, FARAPULSE electrophysiology, and MedSurg expansions. As a leader in minimally invasive devices, BSX’s results set the benchmark against Medtronic and Stryker—diversified medtech giants navigating tariffs, procedural rebounds, and innovation.
Arm, the leading provider of energy-efficient processor designs powering over 99% of smartphones and expanding into AI data centers, faces high scrutiny in Q3 FY2026 (ending Dec 31, 2025). After a strong Q2 with record royalty and licensing revenue, investors are focused on whether AI demand will continue to drive robust growth.
CME Group (CME): Q4 2025 earnings due February 4, 2026; consensus expects adjusted EPS $2.75 and revenue ~$1.6B. S&P Global (SPGI): Q4 2025 earnings due February 10, 2026; Q3 posted EPS $4.73 and 9% revenue growth, driven by Ratings, Indices, and Market Intelligence.
Datadog (DDOG) has come under pressure in recent sessions as volatility across the software sector weighs on sentiment ahead of earnings. Trading in the $108–120 range following a pullback from highs near $200, the stock reflects a disconnect between near-term market caution and resilient underlying fundamentals.
Starbucks shares have shown renewed strength in recent trading, rebounding from earlier lows within a 52-week range of $75.50 to $117.46. The recovery reflects improving comparable sales trends and a return to transaction growth, suggesting early progress from operational initiatives aimed at reconnecting with customers.
DoorDash holds a Strong Buy consensus from 33 analysts, with an average 12-month price target of $280.82, implying more than 40% upside from recent trading levels.
Amazon’s Q4 report capped a strong year marked by accelerating cloud growth, steady retail execution, and expanding advertising profitability. The results reinforced Amazon’s positioning as a core beneficiary of enterprise AI demand, particularly through AWS, while highlighting improving operating leverage across the broader business.
ConocoPhillips reported Q4 2025 adjusted EPS of $1.02, below consensus of $1.08, driven by weaker realized commodity prices.
ICE reported Q4 2025 net revenues of $2.5 billion, up 8% year-over-year, capping 20 consecutive years of record annual revenues at $9.9 billion.
Eli Lilly’s Q4 results highlight explosive growth from GLP-1 therapies, cementing leadership in obesity and diabetes. The company’s strong revenue beat and robust 2026 guidance illustrate high-growth pharma dynamics. Johnson & Johnson, in contrast, exemplifies a diversified healthcare strategy, combining pharmaceuticals, MedTech, and consumer health for steady expansion.
Eli Lilly (LLY), AbbVie (ABBV), and Merck (MRK) all reported strong Q4 2025 earnings, but the market reacted differently to each, reflecting variations in growth profiles, product concentration, and sector dynamics. AbbVie delivered Q4 revenue of $16.62 billion, up 10% year-over-year, with full-year revenue reaching $61.2 billion, an 8.6% increase. Adjusted EPS came in at $2.71, surpassing consensus, though shares dipped following the report amid ongoing Humira concerns
Novo Nordisk (NVO) reported Q4 2025 EPS of $1.02, surpassing estimates of $0.92, with revenue of $12.53B vs $11.99B expected. Full-year 2025 sales rose 10% at constant exchange rates (CER) to DKK 309B, but 2026 guidance anticipates a 5–13% decline at CER due to pricing pressures. Novartis (NVS) posted Q4 core EPS of $2.03, beating $1.99 estimates; net sales of $13.34B slightly missed consensus. FY sales grew 8%, with core EPS up 17% to $8.98.
MUFG (Mitsubishi UFJ Financial Group) posted Q3 FY2026 profits of ¥1.81 trillion, up 3.7% YoY, on track for its full-year target of ¥2.1 trillion. HSBC is set to report Q4 FY2025 earnings on Feb 25, 2026, with consensus EPS around $1.60; recent quarters showed resilient net interest income (NII) supported by Asia wealth growth.